STAT3 and ovarian carcinoma: IL-6 inhibitors also impacted the STAT3 signaling by reducing STAT3 phosphorylation and the expression of STAT3 downstream anti-apoptotic genes in ovarian cancer (Guo et al., 2010a; Guo et al., 2010b).